This paper is in the following e-collection/theme issue:

HIV/AIDS/STI Prevention and Care (1043) Hygiene and Infection Prevention (374) LGBTQ Issues (543) Prevention and Health Promotion (1362) Surveillance Systems (514) Ethics, Privacy, and Legal Issues (617)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64663, first published .
Impact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys

Impact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys

Impact of Disclosing to Patients the Use of Antiretroviral Resistance Testing Results for Molecular HIV Surveillance: A Randomized Experiment in 2 National Surveys

Authors of this article:

Jeremy Sugarman1, 2 Author Orcid Image ;   Juli Bollinger1 Author Orcid Image ;   Jose Agostini3 Author Orcid Image ;   Kevin Weinfurt4 Author Orcid Image ;   Gail Geller1, 2 Author Orcid Image ;   Sheethal Jose1, 5 Author Orcid Image ;   Marissa Hannah3 Author Orcid Image ;   O. Winslow Edwards3 Author Orcid Image ;   Leslie Meltzer Henry1, 6 Author Orcid Image ;   Travis Sanchez3 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.